Microbix Biosystms (TSE:MBX) has released an update.
Microbix Biosystems has announced successful validation of its HPV Quality Assessment Product (QAP) for self-collected samples, showing 100% concordance across various media and assays. This advancement could enhance cervical cancer screening by allowing more women to participate through home sample collection.
For further insights into TSE:MBX stock, check out TipRanks’ Stock Analysis page.
